Chemcon Speciality Chemicals Ltd (CHEMCON) AI Stock Analysis

• Market Cap: ₹8.36B
• Dividend Yield: N/A
• Average Volume (3M): 17.65K
• Price to Earnings (P/E): 32.8
• Beta (1Y): 1.01
• Revenue Growth: -7.67%
• EPS Growth: 36.60%
• Country: IN
• Employees: 220
• Sector: Basic Materials
• Sector Strength: 60
• Industry: Chemicals - Specialty
• EPS (TTM): 1.74
• Shares Outstanding: 36,630,700
• 10 Day Avg. Volume: 36,554
• 30 Day Avg. Volume: 17,654
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹254.00
• Price Target Upside: 11.28% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 69 Neutral
• Price Target: ₹254.00 ▲(11.28% Upside)

Chemcon Speciality Chemicals Ltd's overall score is driven primarily by its strong technical indicators and solid financial foundation. The bullish market momentum reflects positive investor sentiment, although caution is warranted due to the high P/E ratio. Financial performance is balanced, showing operational efficiency but some pressure on margins and cash flow variability. The absence of earnings call insights and corporate events limits additional context.

Chemcon Speciality Chemicals Ltd Business Overview & Revenue Model

Company Description

Chemcon Speciality Chemicals Ltd (CHEMCON) is a leading manufacturer of specialized chemicals, catering primarily to the pharmaceutical and oilfield industries. The company produces a diverse range of products, including pharmaceutical intermediates and oilfield chemicals. These products play crucial roles in various applications, such as drug formulation and oil extraction processes, making CHEMCON an essential supplier in its sectors.

How the Company Makes Money

Chemcon Speciality Chemicals Ltd generates revenue through the manufacturing and sale of specialty chemicals, which are primarily divided into pharmaceutical intermediates and oilfield chemicals. The pharmaceutical intermediates are supplied to pharmaceutical companies for use in the production of active pharmaceutical ingredients (APIs), thus forming a significant portion of the company's income. The oilfield chemicals are utilized in oil and gas exploration activities, providing another key revenue stream. CHEMCON's revenue model is bolstered by long-term relationships with major clients, strategic partnerships, and a strong distribution network that ensures its products reach a wide range of industrial users. Additionally, the company benefits from its focus on quality and innovation, which helps in maintaining a competitive edge in the specialty chemicals market.

Chemcon Speciality Chemicals Ltd Financial Statement Overview

Summary

Chemcon Speciality Chemicals Ltd exhibits a balanced financial performance. Despite operational efficiency and a solid equity base, challenges in maintaining revenue and net profit margins, along with volatile free cash flow, suggest cautious cash management is needed to sustain growth.

Income Statement

Chemcon Speciality Chemicals Ltd shows a mixed performance in its income statement. The gross profit margin is healthy, indicating effective cost management. However, the net profit margin and revenue growth rate have been declining, which may point to challenges in maintaining profitability. Additionally, the EBIT and EBITDA margins are solid, suggesting operational efficiency despite recent revenue contractions.

Balance Sheet

The company's balance sheet reflects a strong equity position with a low debt-to-equity ratio, suggesting financial stability and low leverage risk. The return on equity is moderate, indicating reasonable profitability relative to shareholder investments but with room for improvement. The equity ratio further underscores the company's solid financial foundation, with equity constituting a significant portion of total assets.

Cash Flow

Chemcon's cash flow statement presents a cautious picture. The operating cash flow to net income ratio is robust, indicating efficient cash generation from operations. However, the free cash flow has been volatile, showing significant fluctuations, which could impact liquidity and investment capacity. The free cash flow to net income ratio also mirrors this variability, highlighting potential challenges in sustaining cash flow levels.

Breakdown	Mar 2025	Mar 2024	Mar 2023	Mar 2021	Mar 2022
Income Statement
Total Revenue	2.07B	2.67B	3.03B	2.43B	2.57B
Gross Profit	869.50M	758.95M	1.27B	1.09B	1.17B
EBITDA	328.58M	400.64M	840.11M	852.15M	908.34M
Net Income	244.52M	191.93M	551.10M	563.98M	627.57M
Balance Sheet
Total Assets	5.54B	5.45B	5.53B	4.04B	4.98B
Cash, Cash Equivalents and Short-Term Investments	1.51B	230.80M	1.35B	512.00M	1.12B
Total Debt	246.90M	427.39M	640.15M	62.26M	360.20M
Total Liabilities	532.81M	688.34M	959.98M	498.92M	808.06M
Stockholders Equity	5.01B	4.76B	4.57B	3.54B	4.17B
Cash Flow
Free Cash Flow	309.45M	-308.77M	-334.54M	331.71M	241.36M
Operating Cash Flow	405.17M	119.64M	127.43M	650.30M	742.22M
Investing Cash Flow	-189.15M	-245.58M	-163.41M	-1.52B	-925.48M
Financing Cash Flow	-215.42M	-247.73M	120.41M	1.11B	298.18M

Chemcon Speciality Chemicals Ltd Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 228.25
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:CHEMCON, the sentiment is Positive. The current price of 228.25 is above the 20-day moving average (MA) of 225.45, above the 50-day MA of 208.77, and above the 200-day MA of 210.86, indicating a bullish trend. The MACD of 6.66 indicates Positive momentum. The RSI at 56.15 is Neutral, neither overbought nor oversold. The STOCH value of 33.03 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:CHEMCON.

Chemcon Speciality Chemicals Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CHEMCON	69 Neutral	₹8.36B	32.80		―	-7.67%	36.60%
SHREEPUSHK	67 Neutral	₹12.99B	22.02		0.38%	16.35%	55.54%
CHEMBOND	62 Neutral	₹2.33B	7.07		0.97%	-21.38%	-24.50%
ESTER	59 Neutral	₹10.16B	42.75		0.41%	22.18%	―
HPIL	54 Neutral	₹1.48B	90.17		34.59%	2.32%	-1.91%
BODALCHEM	52 Neutral	₹8.73B	29.89		0.17%	19.75%	844.66%
Sector *	44 Neutral	C$923.76M	-8.68	-0.23%	2.69%	24.53%	-41.45%